• Explore /
  • Poster
  • / Pelvic SABR with HDR boost in intermediate- and high-risk prostate cancer (SPARE): Favorable early toxicity and quality-of-life outcomes.

Pelvic SABR with HDR boost in intermediate- and high-risk prostate cancer (SPARE): Favorable early toxicity and quality-of-life outcomes.

Abstract Poster

Authors

null

Hima Bindu Musunuru

Department of Radiation Oncology, Sunnybrook Health Sciences, University of Toronto, Homestead, PA

Hima Bindu Musunuru , Andrea Deabreu , Melanie Davidson , Ananth Ravi , Joelle Antoine Helou , Ling Ho , Patrick Cheung , Danny Vesprini , Stanley K. Liu , William Chu , Renee Korol , Hans T. Chung , Alexandre Mamedov , Liying Zhang , Andrew Loblaw

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Localized Disease

Clinical Trial Registration Number

REB 269-2014

Citation

J Clin Oncol 35, 2017 (suppl 6S; abstract 60)

DOI

10.1200/JCO.2017.35.6_suppl.60

Abstract #

60

Poster Bd #

C23

Abstract Disclosures

Similar Posters

First Author: Andrew Loblaw

First Author: Luca Faustino Valle

Poster

2019 Genitourinary Cancers Symposium

Multi-institutional analysis of high-risk prostate cancer patients treated with stereotactic body radiotherapy.

Multi-institutional analysis of high-risk prostate cancer patients treated with stereotactic body radiotherapy.

First Author: Naomi Y Jiang

First Author: Stephanie Rice